The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Pulmonary Wedge Pressure

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pulmonary Wedge Pressure


High impact information on Pulmonary Wedge Pressure


Chemical compound and disease context of Pulmonary Wedge Pressure


Biological context of Pulmonary Wedge Pressure


Anatomical context of Pulmonary Wedge Pressure


Associations of Pulmonary Wedge Pressure with chemical compounds


Gene context of Pulmonary Wedge Pressure

  • Both the driving pressure obtained as pulmonary arterial pressure minus wedge pressure and the PaO2 under room air were significantly correlated with the concentrations of IL-6 and TNF-alpha in the BALF [29].
  • Cardiac output and pulmonary capillary wedge pressure had a linear correlation with plasma endothelin-1 levels [30].
  • In group B, significant correlations were found between the peak of MCP-1 and the peak of C-reactive protein levels (r = 0.55, p < 0.02) as well as wedge pressure (r = 0.40, p < 0.05) [31].
  • If this were so, then (1) tachypnea alone, without exercise, should cause the FRC and intracardiac pressures to increase in patients with COPD, (2) there should be an increase in FRC associated with the rise in wedge pressure on exercise, and (3) these changes should not occur in patients without COPD [32].
  • RESULTS: There were positive correlations between peak MMP-1 level, and peak creatine kinase value and pulmonary capillary wedge pressure and peak IL-6 level (r = 0.43, r = 0.70, and r = 0.60, respectively) in all patients [33].

Analytical, diagnostic and therapeutic context of Pulmonary Wedge Pressure


  1. Verapamil in the management of supraventricular tachyarrhythmias occurring after a recent myocardial infarction. Hagemeijer, F. Circulation (1978) [Pubmed]
  2. Normal exercise capacity in patients with severe left ventricular dysfunction: compensatory mechanisms. Litchfield, R.L., Kerber, R.E., Benge, J.W., Mark, A.L., Sopko, J., Bhatnagar, R.K., Marcus, M.L. Circulation (1982) [Pubmed]
  3. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Middlekauff, H.R., Stevenson, W.G., Stevenson, L.W. Circulation (1991) [Pubmed]
  4. Protection of ischemic myocardium by nitroglycerin: experimental and clinical results. Epstein, S.E., Borer, J.S., Kent, K.M., Redwood, D.R., Goldstein, R.E., Levitt, B. Circulation (1976) [Pubmed]
  5. Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock. Richard, C., Ricome, J.L., Rimailho, A., Bottineau, G., Auzepy, P. Circulation (1983) [Pubmed]
  6. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. Raine, A.E., Erne, P., Bürgisser, E., Müller, F.B., Bolli, P., Burkart, F., Bühler, F.R. N. Engl. J. Med. (1986) [Pubmed]
  7. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. Cody, R.J., Atlas, S.A., Laragh, J.H., Kubo, S.H., Covit, A.B., Ryman, K.S., Shaknovich, A., Pondolfino, K., Clark, M., Camargo, M.J. J. Clin. Invest. (1986) [Pubmed]
  8. Effect of furosemide in canine low-pressure pulmonary edema. Ali, J., Chernicki, W., Wood, L.D. J. Clin. Invest. (1979) [Pubmed]
  9. Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study. Hermann, H.P., Pieske, B., Schwarzmüller, E., Keul, J., Just, H., Hasenfuss, G. Lancet (1999) [Pubmed]
  10. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Waagstein, F., Bristow, M.R., Swedberg, K., Camerini, F., Fowler, M.B., Silver, M.A., Gilbert, E.M., Johnson, M.R., Goss, F.G., Hjalmarson, A. Lancet (1993) [Pubmed]
  11. Use of an ultrashort-acting beta-receptor blocker (esmolol) in patients with acute myocardial ischemia and relative contraindications to beta-blockade therapy. Kirshenbaum, J.M., Kloner, R.F., McGowan, N., Antman, E.M. J. Am. Coll. Cardiol. (1988) [Pubmed]
  12. Use of isradipine in hypertension following coronary artery bypass surgery. Underwood, S.M., Feneck, R.O., Davies, S.W., Walesby, R.K., Lunnon, M.W. Am. J. Med. (1989) [Pubmed]
  13. Hemodynamic effects of nitroprusside and furosemide in left ventricular failure. Franciosa, J.A., Silverstein, S.R. Clin. Pharmacol. Ther. (1982) [Pubmed]
  14. Pulmonary edema during IL-2 therapy: combined effect of increased permeability and hydrostatic pressure. Berthiaume, Y., Boiteau, P., Fick, G., Kloiber, R., Sinclair, G.D., Fong, C., Poon, M.C., Lafrenière, R. Am. J. Respir. Crit. Care Med. (1995) [Pubmed]
  15. Pulmonary artery wedge pressure may fail to reflect left ventricular end-diastolic pressure in dogs with oleic acid-induced pulmonary edema. Johnston, W.E., Prough, D.S., Royster, R.L., Howard, G., Johnson, J.C., McLees, B.D. Crit. Care Med. (1985) [Pubmed]
  16. Right ventricular-vascular interaction in congestive heart failure. Importance of low-frequency impedance. Kussmaul, W.G., Altschuler, J.A., Matthai, W.H., Laskey, W.K. Circulation (1993) [Pubmed]
  17. Effects of nitroprusside on transmitral flow velocity patterns in extreme heart failure: a combined hemodynamic and Doppler echocardiographic study of varying loading conditions. Masuyama, T., St Goar, F.G., Alderman, E.L., Popp, R.L. J. Am. Coll. Cardiol. (1990) [Pubmed]
  18. Systemic and pulmonary hemodynamic responses to nicardipine during graded ergometric exercise in patients with moderate to severe essential hypertension. Cody, R.J., Kubo, S.H., Ryman, K.S., Shaknovich, A., Laragh, J.H. J. Am. Coll. Cardiol. (1987) [Pubmed]
  19. Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside. Leslie, J., Brister, N., Levy, J.H., Yared, J.P., Marty, A., Martin, H., Hines, R., Savino, J., Cohen, M. Circulation (1994) [Pubmed]
  20. Intraoperative and percutaneous stenting of congenital pulmonary artery and vein stenosis. Mendelsohn, A.M., Bove, E.L., Lupinetti, F.M., Crowley, D.C., Lloyd, T.R., Fedderly, R.T., Beekman, R.H. Circulation (1993) [Pubmed]
  21. Response of extravascular lung water to intraoperative fluids. Shires, G.T., Peitzman, A.B., Albert, S.A., Illner, H., Silane, M.F., Perry, M.O., Shires, G.T. Ann. Surg. (1983) [Pubmed]
  22. Effect of nitroglycerin during hemodynamic estimation of valve orifice in patients with mitral stenosis. Halperin, J.L., Rothlauf, E.B., Brooks, K.M., Mindich, B.P., Ambrose, J.A. J. Am. Coll. Cardiol. (1987) [Pubmed]
  23. Extravascular lung water in patients with congestive heart failure. Difference between patients with acute and chronic myocardial disease. Grover, M., Slutsky, R.A., Higgins, C.B., Shabetai, R. Radiology. (1983) [Pubmed]
  24. Hemodynamic evaluation of octreotide in patients with hepatitis B-related cirrhosis. Lin, H.C., Tsai, Y.T., Lee, F.Y., Lee, S.D., Hsia, H.C., Lin, W.J., Lo, K.J. Gastroenterology (1992) [Pubmed]
  25. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure. Jordan, R.A., Seth, L., Casebolt, P., Hayes, M.J., Wilen, M.M., Franciosa, J. Ann. Intern. Med. (1986) [Pubmed]
  26. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ayus, J.C., Varon, J., Arieff, A.I. Ann. Intern. Med. (2000) [Pubmed]
  27. Systemic and regional hemodynamic effects of captopril and milrinone administered alone and concomitantly in patients with heart failure. LeJemtel, T.H., Maskin, C.S., Mancini, D., Sinoway, L., Feld, H., Chadwick, B. Circulation (1985) [Pubmed]
  28. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Tsutamoto, T., Wada, A., Maeda, K., Hisanaga, T., Maeda, Y., Fukai, D., Ohnishi, M., Sugimoto, Y., Kinoshita, M. Circulation (1997) [Pubmed]
  29. Inflammatory cytokines in BAL fluid and pulmonary hemodynamics in high-altitude pulmonary edema. Kubo, K., Hanaoka, M., Hayano, T., Miyahara, T., Hachiya, T., Hayasaka, M., Koizumi, T., Fujimoto, K., Kobayashi, T., Honda, T. Respiration physiology. (1998) [Pubmed]
  30. Plasma endothelin levels and surgically correctable pulmonary hypertension. Chang, H., Wu, G.J., Wang, S.M., Hung, C.R. Ann. Thorac. Surg. (1993) [Pubmed]
  31. Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling. Parissis, J.T., Adamopoulos, S., Venetsanou, K.F., Mentzikof, D.G., Karas, S.M., Kremastinos, D.T. J. Interferon Cytokine Res. (2002) [Pubmed]
  32. Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Butler, J., Schrijen, F., Henriquez, A., Polu, J.M., Albert, R.K. Am. Rev. Respir. Dis. (1988) [Pubmed]
  33. Extracellular matrix disturbances in acute myocardial infarction: relation between disease severity and matrix metalloproteinase-1, and effects of magnesium pretreatment on reperfusion injury. Ueshima, K., Shibata, M., Suzuki, T., Endo, S., Hiramori, K. Magnesium research : official organ of the International Society for the Development of Research on Magnesium. (2003) [Pubmed]
  34. Cardiac involvement in thalassemia intermedia: a multicenter study. Aessopos, A., Farmakis, D., Karagiorga, M., Voskaridou, E., Loutradi, A., Hatziliami, A., Joussef, J., Rombos, J., Loukopoulos, D. Blood (2001) [Pubmed]
  35. Noncirrhotic portal hypertension in congenital cytomegalovirus infection. Ghishan, F.K., Greene, H.L., Halter, S., Barnard, J.A., Moran, J.R. Hepatology (1984) [Pubmed]
  36. The effect of food on pharmacokinetics and pharmacodynamics of fenoldopam in class III heart failure. Blanchett, D.G., Green, J.A., Nara, A., Pospisil, R., Jarvis, R.C., Kasmer, R.J., Boyle, D.A., Cyronak, M.J., Corder, C.N. Clin. Pharmacol. Ther. (1991) [Pubmed]
  37. Alternations in atrial natriuretic peptide release after DC cardioversion of non-valvular chronic atrial fibrillation. Arakawa, M., Miwa, H., Noda, T., Ito, Y., Kambara, K., Kagawa, K., Nishigaki, K., Kano, A., Hirakawa, S. Eur. Heart J. (1995) [Pubmed]
  38. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Briegel, J., Forst, H., Haller, M., Schelling, G., Kilger, E., Kuprat, G., Hemmer, B., Hummel, T., Lenhart, A., Heyduck, M., Stoll, C., Peter, K. Crit. Care Med. (1999) [Pubmed]
WikiGenes - Universities